120 patients. International sites. The largest prospective FDA IDE trial ever run for Y90 radioembolization.
#livercancer #HCC #Oncology
120 patients. International sites. The largest prospective FDA IDE trial ever run for Y90 radioembolization.
#livercancer #HCC #Oncology
Read more: cancer.mcw.edu/stories/rout...
Read more: cancer.mcw.edu/stories/rout...
A sincere thank you to Dr. Rajvot Dhatt, his outstanding team at Vancouver General Hospital, and all other contributors supporting this study.
A sincere thank you to Dr. Rajvot Dhatt, his outstanding team at Vancouver General Hospital, and all other contributors supporting this study.
ABK Biomedical is proud to support & contribute to the growing field of IO with an innovative approach to radioembolization with Eye90 microspheres® and our Route90 clinical trial.
www.ioawareness.org
#IOAwarenessWeek #Y90 #IKnowIO
ABK Biomedical is proud to support & contribute to the growing field of IO with an innovative approach to radioembolization with Eye90 microspheres® and our Route90 clinical trial.
www.ioawareness.org
#IOAwarenessWeek #Y90 #IKnowIO